Form 8-K - Current report:
SEC Accession No. 0001493152-25-014965
Filing Date
2025-09-25
Accepted
2025-09-25 17:05:45
Documents
21
Period of Report
2025-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 64176
2 EX-4.1 ex4-1.htm EX-4.1 160522
3 EX-4.2 ex4-2.htm EX-4.2 129098
4 EX-10.1 ex10-1.htm EX-10.1 343654
5 EX-10.2 ex10-2.htm EX-10.2 209061
6 EX-10.3 ex10-3.htm EX-10.3 62023
7 EX-10.4 ex10-4.htm EX-10.4 56237
8 EX-10.5 ex10-5.htm EX-10.5 72650
9 EX-10.6 ex10-6.htm EX-10.6 102781
10 EX-99.1 ex99-1.htm EX-99.1 19792
  Complete submission text file 0001493152-25-014965.txt   1623142

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE qlgn-20250919.xsd EX-101.SCH 3008
12 XBRL LABEL FILE qlgn-20250919_lab.xml EX-101.LAB 34239
13 XBRL PRESENTATION FILE qlgn-20250919_pre.xml EX-101.PRE 22354
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3697
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 251344597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)